Jiří Vencovský

37.4k total citations · 4 hit papers
267 papers, 12.6k citations indexed

About

Jiří Vencovský is a scholar working on Rheumatology, Epidemiology and Immunology. According to data from OpenAlex, Jiří Vencovský has authored 267 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Rheumatology, 103 papers in Epidemiology and 82 papers in Immunology. Recurrent topics in Jiří Vencovský's work include Inflammatory Myopathies and Dermatomyositis (99 papers), Rheumatoid Arthritis Research and Therapies (80 papers) and Systemic Sclerosis and Related Diseases (36 papers). Jiří Vencovský is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (99 papers), Rheumatoid Arthritis Research and Therapies (80 papers) and Systemic Sclerosis and Related Diseases (36 papers). Jiří Vencovský collaborates with scholars based in Czechia, United Kingdom and United States. Jiří Vencovský's co-authors include Ladislav Šenolt, Karel Pavelká, Michal Tomčík, Martin Komarc, Maja Špiritović, Hana Štorkánová, Sabína Oreská, Barbora Heřmánková, Radim Bečvář and Kristýna Bubová and has published in prestigious journals such as The Lancet, PLoS ONE and The Journal of Physiology.

In The Last Decade

Jiří Vencovský

253 papers receiving 12.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

2021 4.1k citations Hana Štorkánová, Sabína Oreská et al. profile →
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

2016 689 citations Jiří Vencovský et al. profile →
119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

2004 668 citations Ernest Choy, Ingrid E. Lundberg et al. profile →
Idiopathic inflammatory myopathies

2021 347 citations Ingrid E. Lundberg, Jiří Vencovský et al. profile →

Peers

Countries citing papers authored by Jiří Vencovský

Since Specialization

Citations

This map shows the geographic impact of Jiří Vencovský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Vencovský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Vencovský more than expected).

Fields of papers citing papers by Jiří Vencovský

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiří Vencovský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Vencovský. The network helps show where Jiří Vencovský may publish in the future.

Co-authorship network of co-authors of Jiří Vencovský

This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Vencovský. A scholar is included among the top collaborators of Jiří Vencovský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Vencovský. Jiří Vencovský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study 2025 ·Rheumatology and Therapy ·Rohit Aggarwal, Joachim Schessl, Zsuzsanna Bata‐Csörgõ, Mazen M. Dimachkie, Zoltán Griger, Sergey Moiseev, Chester V. Oddis, Elena Schiopu, Jiří Vencovský, (unknown), Todd Levine, Christina Charles‐Schoeman, (unknown)	0
2	Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years 2024 ·Rheumatology and Therapy ·Christina Charles‐Schoeman, Jon T. Giles, Nancy E. Lane, Ernest Choy, Daniel E. Fürst, Jiří Vencovský, Anthony G. Wilson, Gerd R Burmester, Derek Coombs, (unknown), Nasser Khan, (unknown), (unknown), Iain B. McInnes	5
3	Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-α inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry 2024 ·Scandinavian Journal of Rheumatology ·(unknown), (unknown), (unknown), Jiří Vencovský, Karel Pavelká, Pavel Hořák, Jakub Závada	0
4	Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome 2023 ·Arthritis & Rheumatology ·Blanka Stibůrková, Kateřina Pavelcová, Monika Beličková, (unknown), Jason C. Collins, Achim Werner, David B. Beck, (unknown), Cyril Šálek, (unknown), H. Mann, Jiří Vencovský	33
5	S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin 2023 ·Lara D. Veeken ·(unknown), Hana Štorkánová, Thuong Trinh‐Minh, (unknown), (unknown), Hana Hulejová, Sabína Oreská, Barbora Heřmánková, Radim Bečvář, Karel Pavelká, Jiří Vencovský, Jörg Klingelhöfer, Rizwan I. Hussain, Jonas Hallén, Ladislav Šenolt, Jörg H. W. Distler, Michal Tomčík	6
6	Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study 2023 ·Rheumatology and Therapy ·Barbora Heřmánková, Maja Špiritović, Sabína Oreská, Hana Štorkánová, H. Mann, Karel Pavelká, Ladislav Šenolt, Jiří Vencovský, Radim Bečvář, Michal Tomčík	1
7	Cardiovascular risk in myositis patients compared with the general population 2023 ·Lara D. Veeken ·Sabína Oreská, Hana Štorkánová, (unknown), Jaroslav Kudlička, Vladimír Tuka, (unknown), (unknown), (unknown), Eva Chytilova, J Kvasnička, Maja Špiritović, Barbora Heřmánková, (unknown), (unknown), Karel Pavelká, Ladislav Šenolt, H. Mann, Jiří Vencovský, Michal Vráblík, Michal Tomčík	9
8	Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study 2022 ·Lara D. Veeken ·N. Cordel, (unknown), F. Jouen, Janine A. Lamb, Hector Chinoy, Paul New, Jiří Vencovský, H. Mann, Angeles S. Galindo‐Feria, Lara Dani, Albert Selva-O’Callaghan, Victoria P. Werth, (unknown), Océane Landon‐Cardinal, B. Tressières, Olivier Boyer	5
9	The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry 2022 ·Rheumatology International ·(unknown), (unknown), H. Mann, Jakub Závada, (unknown), Jiří Vencovský, Karel Pavelká, Pavel Hořák, (unknown)	7
10	Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study 2021 ·Lara D. Veeken ·Barbora Heřmánková, Maja Špiritović, Sabína Oreská, Hana Štorkánová, Martin Komarc, Martin Klein, H. Mann, Karel Pavelká, Ladislav Šenolt, Jiří Vencovský, Michal Tomčík	8
11	Interleukin-35 in idiopathic inflammatory myopathies 2020 ·Cytokine ·H. Mann, Olga Kryštůfková, Josef Zámečnı́k, Jaromír Háček, Hana Hulejová, Mária Filková, Jiří Vencovský, Ladislav Šenolt	5
12	Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study 2019 ·Rheumatology International ·Hana Hulejová, (unknown), Kristýna Bubová, Olga Kryštůfková, Mária Filková, H. Mann, Šárka Forejtová, Michal Tomčík, Jiří Vencovský, Karel Pavelká, Ladislav Šenolt	6
13	Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis 2019 ·Lara D. Veeken ·Zoë Betteridge, Hector Chinoy, Jiří Vencovský, J. Winer, (unknown), Pauline Ho, Ingrid E. Lundberg, Katalin Dankó, Robert G. Cooper, Neil McHugh	13
14	Mavrilimumab, a Fully Human Granulocyte–Macrophage Colony‐Stimulating Factor Receptor α Monoclonal Antibody 2018 ·Arthritis & Rheumatology ·Gerd R Burmester, Iain B. McInnes, Joel M. Kremer, Pedro C. Miranda, Jiří Vencovský, A. Godwood, (unknown), (unknown), Xiang Guo, D. Close, Michael E. Weinblatt	62
15	A Randomized Phase II b Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis 2017 ·Arthritis & Rheumatology ·Michael E. Weinblatt, Iain B. McInnes, Joel M. Kremer, Pedro C. Miranda, Jiří Vencovský, Xiang Guo, Wendy I. White, Patricia C. Ryan, A. Godwood, (unknown), D. Close, Gerd R Burmester	72
16	Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study 2017 ·PLoS ONE ·(unknown), Hana Hulejová, Jakub Závada, Petra Hánová, Martin Komarc, H. Mann, Martin Klein, (unknown), Marta Olejarová, Šárka Forejtová, Olga Růžičková, Jiří Vencovský, Karel Pavelká, Ladislav Šenolt	28
17	Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission 2016 ·PLoS ONE ·(unknown), Hana Hulejová, Jakub Závada, Martin Komarc, Petra Hánová, Martin Klein, H. Mann, (unknown), Marta Olejarová, Šárka Forejtová, Olga Růžičková, Jiří Vencovský, Karel Pavelká, Ladislav Šenolt	14
18	Clinical Differences Between Adult and Juvenile Dermatomyositis Associated with Anti-NXP2 Autoantibodies. 2012 ·UCL Discovery (University College London) ·Sarah Tansley, Zoë Betteridge, Harsha Gunawardena, Lucy R. Wedderburn, Hector Chinoy, RG Cooper, Jiří Vencovský, Lenka Pleštilová, Ingrid E. Lundberg, Katalin Dankó, (unknown), NJ McHugh	1
19	Inter-rater reliability and validity of two disease activity assessment tools in patients with idiopathic inflammatory myositis (IIM) 2005 ·UCL Discovery (University College London) ·(unknown), Elizabeth Allen, Patrick Kiely, RG Cooper, (unknown), Jiří Vencovský, Ingrid E. Lundberg, (unknown), Michael G. Hanna, David Isenberg	1
20	Tumour necrosis factor α G→A −238 and G→A −308 polymorphisms in juvenile idiopathic arthritis 2002 ·Lara D. Veeken ·Seza Özen, Mehmet Alikaşifoğlu, Ayşı̇n Bakkaloğlu, Ali Düzova, Kateřina Jarošová, Dana Němcová, Nesrin Beşbaş, Jiří Vencovský, E Tunçbilek	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact